CN Patent

CN105007915B — 包含peg和抗坏血酸的组合物

Assigned to Norgine BV · Expires 2018-09-28 · 8y expired

What this patent protects

本发明提供了结肠清洗溶液，其包含：a)300‑800mmol/L抗坏血酸阴离子，其由(i)抗坏血酸和(ii)一种或多种抗坏血酸的盐的混合物提供，所述组分(i)和(ii)以1:4.5‑1:7.0的摩尔比存在；和b)10‑200g/L聚乙二醇。本发明还提供了与试剂盒相关的方法、或使用所述溶液的方法、以及用于制备所述溶液的组合物。

USPTO Abstract

本发明提供了结肠清洗溶液，其包含：a)300‑800mmol/L抗坏血酸阴离子，其由(i)抗坏血酸和(ii)一种或多种抗坏血酸的盐的混合物提供，所述组分(i)和(ii)以1:4.5‑1:7.0的摩尔比存在；和b)10‑200g/L聚乙二醇。本发明还提供了与试剂盒相关的方法、或使用所述溶液的方法、以及用于制备所述溶液的组合物。

Drugs covered by this patent

Infuvite Adult (ASCORBIC ACID)

Patent Metadata

Patent number: CN105007915B
Jurisdiction: CN
Classification: —
Expires: 2018-09-28
Drug substance claim: No
Drug product claim: No
Assignee: Norgine BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.